Details for New Drug Application (NDA): 209024
✉ Email this page to a colleague
The generic ingredient in GLYCOPYRROLATE is glycopyrrolate. There are seventeen drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
Summary for 209024
Tradename: | GLYCOPYRROLATE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | glycopyrrolate |
Patents: | 0 |
Pharmacology for NDA: 209024
Mechanism of Action | Cholinergic Antagonists |
Medical Subject Heading (MeSH) Categories for 209024
Suppliers and Packaging for NDA: 209024
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 209024 | ANDA | Fresenius Kabi USA, LLC | 76045-203 | 76045-203-10 | 24 BLISTER PACK in 1 CARTON (76045-203-10) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-203-01) / 1 mL in 1 SYRINGE, GLASS |
GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 209024 | ANDA | Fresenius Kabi USA, LLC | 76045-203 | 76045-203-20 | 24 BLISTER PACK in 1 CARTON (76045-203-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-203-02) / 2 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.2MG/ML | ||||
Approval Date: | Oct 31, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription